glp 1 cirrhosis Glp–1 and cirrhosis: effects on mortality and liver-related complications Breakthrough of the Year: GLP-1

55 However, the ASA statement has been criticised based on lack of supportive data

Saxenda is not recommended for use in children Important Safety Information What is the most important information I should know about Saxenda

Clinical trials in Alzheimers disease Alzheimers disease is where the 2025 data forced the largest revision, and where the contrast between observational promise and trial outcome is sharpest

Back Baden, A (14 May 2025) 'People who stop weight loss drugs return to original weight within year, analysis finds', The Guardian

This breakthrough allowed peptide drugs to be synthesized at mass scale, without needing to be harvested from animal pancreases, and gave birth to the biotechnology industry